BASF and Transinsight Collaborate in Exploring Alternatives to Animal Testing

Go3RBASF SE and Transinsight GmbH, a provider of semantic search technologies for Web 2.0, have agreed to establish close cooperation in the area of semantic analyses to search for alternatives to animal testing. Together with the German Federal Institute for Risk Assessment, both companies will expand the first specialized semantic search engine for this research area called www.Go3R.org to become a global internet platform. In the future, experts from all over the world will be able to use this platform to bring together their knowledge on alternative and supplementary methods to animal testing.

For over 20 years, BASF has been committed to establishing alternative and supplementary methods. Since 2004, the company has been developing and validating alternatives to animal testing in its own alternatives laboratory with a research budget of 2 million euros per year. Even now alternative methods are employed in 25 percent of all the company's tests. "We are striving to increase this proportion. Transinsight's semantic search supports us in this endeavour. With the help of this highly promising technology, we - just like any other potential user - can browse the internet, internal sources, patents and specialized databases much more efficiently than before when searching for information on meaningful approaches to new alternative methods", explains Dr Robert Landsiedel, Head of the Short Term Toxicology Department at BASF.

Transinsight's semantic search engine also finds related terms and web pages that are relevant for the respective search term and thus provides considerably more accurate and comprehensive search results than conventional full text search engines. "Go3R will make a tremendous contribution to improving the process of searching for information on alternative methods", states Dr Michael R. Alvers, CEO of Transinsight. "To achieve this, we are transferring the Wikipedia concept – the largest internet encyclopaedia compiled by the community – to semantic networks of terms. Currently, this is the most efficient way to achieve a large knowledge base within a short period of time and thus to significantly reduce the amount of animal testing in the long term", Alvers continues. The www.Go3R.org platform is already available online. The service is free of charge.

Related news articles:

About Transinsight
Transinsight develops knowledge-based semantic solutions in the Life Sciences. Their flagship products www.Go3R.org and www.GoPubMed.com, renowned biomedical search engines, are the first knowledge-based search systems of the next generation for the Life Sciences on the internet. In acknowledgement of the technologies developed by the company, Transinsight has repeatedly been honoured with international awards. The firm works in close collaboration with the Dresden University of Technology. Selected customers are: Unilever, BASF, BfR, StatoilHydro, Wintershall, AbCam and EMBL. For further information on Transinsight on the internet, see www.transinsight.com.

About BASF
BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from oil and gas to chemicals, plastics, performance products, agricultural products and fine chemicals. As a reliable partner, BASF helps its customers in virtually all industries to be more successful. With its high-value products and intelligent solutions, BASF plays an important role in finding answers to global challenges, such as climate protection, energy efficiency, nutrition and mobility. BASF has more than 95,000 employees and posted sales of almost 58 billion euros in 2007. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...